United Kingdom· GB-APID-5444311000001105
Amias 8mg tablets
A candesartan product containing candesartan, registered in United Kingdom by Dowelhurst Ltd. The same ATC class is registered in 16 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Candesartan is registered in 16 of 19 countries.
Countries holding a registration under ATC C09CA06 (candesartan), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 9 of them publish a price we can compare per daily dose
Candesartan · ATC C09CA06
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of candesartan costs, country by country.
Normalised to the WHO defined daily dose (8 mg), the median price runs from $0.15 in Italy to $0.36 in Switzerland — a ×2.3 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Candesartan · price per daily dose (8 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.36
- ES Spain$0.21
- IT Italy$0.15
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Candesartan
- Manufacturer
- Dowelhurst Ltd
- Country
- United Kingdom (GB)
- ATC code
- C09CA06
- ATC class
- Candesartan
- Defined daily dose
- 8 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
81 interactions on record for candesartan.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Candesartan · interactions on record
81 records
81 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Candesartan in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/aa1077f3-dc61-4d3e-a9c0-7527db824474 GET /v1/drugs/aa1077f3-dc61-4d3e-a9c0-7527db824474?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "5444311000001105",
"desc": "Amias 8mg tablets (Dowelhurst Ltd)",
"form": "Oral tablet",
"vpid": "42372111000001105",
"source": "dmd",
"vtm_id": "775028007",
"strength": "8 mg",
"substance": "Candesartan",
"ingredient": "Candesartan cilexetil",
"supplier_code": "5283211000001105"
}See everything about candesartan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.